
In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …

Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …

As part of the on-going harmonisation of manufacturing standards across the Atlantic, the EMA and FDA have announced that they …

Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …

New data for AstraZeneca’s blood thinner Brilinta (ticagrelor) has shown that extended use of the drug can cut the risk …

The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …

Novartis has released that it has received marketing approval from the European Commission for its drug for the treatment of …

Janssen has spoken out against plans to use an anaesthetic drug it invented over 50 years ago to execute prisoners, …

Cancer Research UK has announced that its collaboration with Eli Lilly for the treatment of advanced solid tumours will progress …

Researchers from The Institute of Cancer Research have potentially found a new use for Imbruvica, after discovering a weakness in …

Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis …

Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …

It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …

Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout …

It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks …

Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …

Researchers from Vanderbilt University have discovered a previously unknown ability of a compound in mother’s milk to protect new-borns from …